Search
Guaifenesin
go.drugbank.com/drugs/DB00874ApprovedInvestigationalVet approvedAfter the negotiation between FDA and major manufacturers, a voluntary transition of labels for not using guaifenesin in children under the age of 4 years was endorsed by FDA in 2008 [F4525]. … there has also been contemporary research to suggest that guaifenesin possesses and is capable of demonstrating anticonvulsant and muscle relaxant effects to some degree possibly by acting as an NMDA receptor
Mixtures: A-Tan 12X Suspension, Only For COUGHProducts: Mucinex for Kids, Tussin Expectorant for AdultsValproic acid
go.drugbank.com/drugs/DB00313ApprovedInvestigational[L6190] Since then, it has been investigated for neuroprotective, anti-manic, and anti-migraine effects. … [A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century.
Products: 400 mg Powder for injection / infusion, Convulex 50 mg/ml - Sirup für KinderCyclosporine
go.drugbank.com/drugs/DB00091ApprovedInvestigationalVet approvedCyclosporine is a calcineurin inhibitor known for its immunomodulatory properties that prevent organ transplant rejection and treat various inflammatory and autoimmune conditions. … [A174049] Initially manufactured by Sandoz and approved for use by the FDA in 1983, cyclosporine is now available in various products by Novartis (previously known as Sandoz).[L11097,L3734,L11118]
Products: ATOPICA 25MG SOFT CAPSULES FOR DOG, ATOPICA 50MG SOFT CAPSULES FOR DOGFurosemide
go.drugbank.com/drugs/DB00695ApprovedInvestigationalVet approvedIn addition to oral formulations, the solution for intravenous and intramuscular administration is also available, which is typically limited to patients who are unable to take oral medication or for patients … [L7958] Furosemide is used for edema secondary to various clinical conditions, such as congestive heart failure exacerbation, liver failure, renal failure, and high blood pressure.
Categories: Antihypertensive Agents Indicated for HypertensionProducts: FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML, FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 20 MG/2 MLTolevamer
go.drugbank.com/drugs/DB01344ApprovedSodium polystyrene sulfonate is a medication used to treat abnormally high potassium levels. It may be taken orally or by rectum, as an enema, and functions as a potassium-binding resin in the intestines. It is also an effective topical ...
Categories: Drugs for Treatment of Hyperkalemia and HyperphosphatemiaProducts: <p>KALQUEST® Powder for Oral Suspension 5g/sachet</p>, PMS-SODIUM POLYSTYRENE SULFONATE POWDER FOR SUSPENSION 94.3 mg/gOctinoxate
go.drugbank.com/drugs/DB09496ApprovedInvestigationalOctinoxate is a cinnamate ester and common ingredient in sunscreen and other skin care products to minimize DNA photodamage. It was originally developed in 1950's as an organic UV-B filter that absorbs UV-B rays from sun. It is often com...
Mixtures: Soleil Suisse Cellular Self Tan for The Face SPF 15, Soleil Suisse Cellular Self Tan for The Body SPF 15Categories: Protectives Against UV-Radiation for Topical UseValganciclovir
go.drugbank.com/drugs/DB01610ApprovedInvestigationalAs the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases.
Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseProducts: Valganciclovir hydrochloride for OralMitoxantrone
go.drugbank.com/drugs/DB01204ApprovedInvestigationalAn anthracenedione-derived antineoplastic agent.
Products: MITOXANTRONE BAXTER SOLUTION FOR INJECTION 20MG/10ML (2MG/ML)ALLO-715
go.drugbank.com/drugs/DB18640InvestigationalALLO-715 is an allogeneic chimeric antigen receptor T Cell therapy targeting B cell maturation antigen (BCMA).
Synonyms: Allogenic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen (BCMA)Methylprednisolone
go.drugbank.com/drugs/DB00959ApprovedInvestigationalVet approvedMethylprednisolone is a prednisolone derivative glucocorticoid with higher potency than prednisone. It was first described in the literature in the late 1950s. Methylprednisolone was granted FDA approval on 24 October 1957. In the outbre...
Mixtures: Methylprednisolone Sodium Succinate for Injection, USP, Methylprednisolone Sodium Succinate for Injection, USPCategories: Corticosteroids for Systemic Use, Anti-Acne Preparations for Topical Use